Skip to main content
OpenTrials

Clinical trial condition

Myositis, Inclusion Body

Explore clinical trials studying Myositis, Inclusion Body. Study availability and eligibility vary by location and protocol.

53 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Myositis, Inclusion Body trial results

Completed

An Extension Study of the Efficacy, Safety and Tolerability of BYM338 (Bimagrumab) in Patients With Sporadic Inclusion Body Myositis Who Previously Participated in the Core Study CBYM338B2203

NCT02573467

Conditions
Atrophy, Muscular Atrophy, Muscular Diseases, +11 more
Locations
  • Novartis Investigative Site Phoenix, Arizona, United States
  • Novartis Investigative Site Orange, California, United States
  • Novartis Investigative Site Sacramento, California, United States
  • Novartis Investigative Site Miami, Florida, United States
View all 38 locations
View Trial Details
Completed

Efficacy and Safety of Bimagrumab/BYM338 at 52 Weeks on Physical Function, Muscle Strength, Mobility in sIBM Patients

NCT01925209

Conditions
Atrophy, Muscular Atrophy, Muscular Diseases, +11 more
Locations
  • Novartis Investigative Site Phoenix, Arizona, United States
  • Novartis Investigative Site Orange, California, United States
  • Novartis Investigative Site Sacramento, California, United States
  • Novartis Investigative Site Miami, Florida, United States
View all 38 locations
View Trial Details
Completed

Arimoclomol in Sporadic Inclusion Body Myositis

NCT00769860

Conditions
Inclusion Body Myositis, Muscular Diseases, Musculoskeletal Diseases, +4 more
Locations
  • University of Kansas Medical Center Kansas City, Kansas, United States
  • University College London, MRC Centre for Neuromuscular Disease London, United Kingdom
View Trial Details
Completed

Natural History in CCFDN and IBM Syndromes

NCT01902940

Conditions
Congenital Cataracts, Facial Dysmorphism, And Neuropathy, Distal myopathy, Nonaka type, Inclusion Body Myopathy, Autosomal-dominant, +9 more
Locations
  • Friedrich-Baur-Institut, Ludwig-Maximilians-University of Munich Munich, Bavaria, Germany
View Trial Details

Related conditions